Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Regeneron (REGN) Tops Q4 EPS by 58c
February 6, 2020 6:32 AM ESTRegeneron (NASDAQ: REGN) reported Q4 EPS of $7.50, $0.58 better than the analyst estimate of $6.92. Revenue for the quarter came in at $2.17 billion versus the consensus estimate of $2.11 billion.
The Company and Sanofi announced intent to restructure antibody collaboration for Kevzara and Praluent2020... More
